FDA Okays Pfizer/BioNTech Booster for Adolescents and a Patent-Free Vaccine
Low-income countries still struggle to get first jabs into arms. Researchers and pharma companies continue to push for low-cost vaccines and drugs worldwide.
United States Baylor College Of Medicine Pfizerand Biontechfor Maria Elena Bottazzi Albert Bourla Joseph Osmundson
Source: biospace.com